Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May–June, 2020

This paper highlights on the coronavirus outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At the time of writing this paper, there has been over 6 million confirmed cases worldwide. It is a person–person transmittable infection but there have been cases of asymptomatic carriers. Hence, development of an effective biosensing diagnostic tool can curb its rapid transmission rate. The first part of the paper highlights on the SARS-CoV-2 structure and its resemblance to SARS-CoV. The second part of the paper analyzes on the potential application of gold and silver nanoparticles to generate a red shift that had enhanced the calorimetric property of the MERS-CoV analysis due to transition in its optical property. Other electrochemical techniques that utilized the application of gold nanoparticles are also reviewed. Gold and silver nanoparticles (AuNP and Ag NP) can accelerate the sensitivity upon electrodeposition on the diagnostic tool.

Download Full-text

SARS-CoV-2 Virus is Evolving to Adapt : A Fast Check Note

iScience Notes ◽

10.22580/iscinotej5.5.2 ◽

2020 ◽

Vol 5 (5) ◽

pp. 1-5

Author(s):

Subhra Mandal

Keyword(s):

Severe Acute Respiratory Syndrome ◽

Immune Systems ◽

Counter Measures ◽

Adaptive Mutations ◽

The World ◽

Global Spread ◽

Rapid Transmission

Coronavirus Disease 19 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a highly transmissible and pathogenic coronavirus, has spread at an alarming rate throughout the world since Dec. 2019, claiming 2.196 million deaths globally, as per 30th Jan. 2021, and the count is on. The reason behind this ongoing rapid transmission and global spread of SARS-CoV-2 is that the virus is evolving to become more transmissible as it spreads across the world due to its fast host migration. The virus is rapidly evolving to adapt to the different geo‑climate environments, diverse host immune systems, and other protective counter-measures (such as prolong host survival) by accumulating adaptive mutations, deletions, and recombination. This note focuses on those mutations and the prominent viral strains that are noteworthy for epidemiological and biological reasons.

Download Full-text

Recent Update of COVID-19 Vaccines

Advanced Pharmaceutical Bulletin ◽

10.34172/apb.2022.045 ◽

2021 ◽

Author(s):

Sameer A. Jadaan ◽

Abdul Waheed Khan

Keyword(s):

Severe Acute Respiratory Syndrome ◽

Immune Responses ◽

Vital Role ◽

Host Cells ◽

Cellular Immune Responses ◽

Vaccination Strategies ◽

Rapid Transmission ◽

Cellular Immune

Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) has been recently identified as a novel member of beta coronaviruses (CoVs) and the cause of coronavirus disease-2019 (COVID-19). It has been first discovered in China and soon has spread across continents with an escalating number of mortalities. There is an urgent need for developing a COVID-19 vaccine to control the rapid transmission and the deleterious impact of the virus. The potent vaccine should have a good tolerable and efficacious profile to induce target-specific humoral and cellular immune responses. It should also exhibit no or minimal detrimental effects in children, young adults, and elderly people with or without co-morbidities from different racial backgrounds. Previously published findings of Severe Acute Respiratory Syndrome associated Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) played vital role in the characterization of surface spike proteins as the tool of entry of the SARS-CoV-2 into host cells. It has become evident that SARS-CoVs have high genetic similarity and this implies antecedent vaccination strategies could be implicated in the production of COVID-19 vaccines. Although several vaccines have been approved and rolled out, only a handful of them have passed the three phases of clinical studies. This review highlights the completed, and ongoing clinical trials of COVID-19 vaccines and efforts are being made globally to avert the pandemic.

Download Full-text

Perceptions about Severe Acute Respiratory Syndrome Experience Scales

PsycTESTS Dataset ◽

10.1037/t75816-000 ◽

2006 ◽

Author(s):

Robert G. Maunder ◽

William J. Lancee ◽

Kenneth E. Balderson ◽

Jocelyn P. Bennett ◽

Bjug Borgundvaag ◽

...

Keyword(s):

Severe Acute Respiratory Syndrome

Download Full-text

Restorative dental treatment in times of COVID-19

RGO - Revista Gaúcha de Odontologia ◽

10.1590/1981-863720200001920200075 ◽

2020 ◽

Vol 68 ◽

Author(s):

Robson de Lima GOMES ◽

Marlus da Silva PEDROSA ◽

Claudio Heliomar Vicente da SILVA

Keyword(s):

Severe Acute Respiratory Syndrome ◽

Dental Treatment ◽

Close Contact ◽

Cross Contamination ◽

Clinical Protocols ◽

Know How ◽

Dental Procedures ◽

Dental Staff ◽

Dental Professional ◽

Restrictive Measures

ABSTRACT Since the outbreak of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), numerous restrictive measures have been adopted by governments of different countries. The return to elective dental care in Brazil is a reality even during the COVID-19 pandemic. During restorative dental procedures, the dental professional requires close contact with the patient, being exposed to contaminated saliva and fluids. In addition, transmission of COVID-19 by the generation of aerosol produced by dental handipieces may be possible. Thus, the dental staff must know how to act during restorative dental procedures, putting into practice the correct clinical protocols to avoid cross-contamination and COVID-19 spread. The purpose of this article is to review the literature on the biosafety practices especially in the context of restorative dental procedures in times of COVID-19.

Download Full-text

In Silico Molecular Docking and Molecular Dynamic Simulation of Potential Inhibitors of 3C-like Main Proteinase (3CLpro) from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Using Selected African Medicinal Plants

10.26434/chemrxiv.12480434.v1 ◽

2020 ◽

Author(s):

Sahar Qazi ◽

Mustafa Alhaji Isa ◽

Adam Mustapha ◽

Khalid Raza ◽

Ibrahim Alkali Allamin ◽

...

Keyword(s):

Molecular Docking ◽

Severe Acute Respiratory Syndrome ◽

In Silico ◽

Md Simulation ◽

Binding Energies ◽

Anacardium Occidentale ◽

Upper Respiratory Tract ◽

Ligand Complex ◽

In Silico Docking ◽

Main Protease

The Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) is an infectious virus that causes mild to severe life-threatening upper respiratory tract infection. The virus emerged in Wuhan, China in 2019, and later spread across the globe. Its genome has been completely sequenced and based on the genomic information, the virus possessed 3C-Like Main Protease (3CLpro), an essential multifunctional enzyme that plays a vital role in the replication and transcription of the virus by cleaving polyprotein at eleven various sites to produce different non-structural proteins. This makes the protein an important target for drug design and discovery. Herein, we analyzed the interaction between the 3CLpro and potential inhibitory compounds identified from the extracts of Zingiber offinale and Anacardium occidentale using in silico docking and Molecular Dynamics (MD) Simulation. The crystal structure of SARS-CoV-2 main protease in complex with 02J (5-Methylisoxazole-3-carboxylic acid) and PEJ (composite ligand) (PDB Code: 6LU7,2.16Å) retrieved from Protein Data Bank (PDB) and subject to structure optimization and energy minimization. A total of twenty-nine compounds were obtained from the extracts of Zingiber offinale and the leaves of Anacardium occidentale. These compounds were screened for physicochemical (Lipinski rule of five, Veber rule, and Egan filter), Pan-Assay Interference Structure (PAINS), and pharmacokinetic properties to determine the Pharmaceutical Active Ingredients (PAIs). Of the 29 compounds, only nineteen (19) possessed drug-likeness properties with efficient oral bioavailability and less toxicity. These compounds subjected to molecular docking analysis to determine their binding energies with the 3CLpro. The result of the analysis indicated that the free binding energies of the compounds ranged between ˗5.08 and -10.24kcal/mol, better than the binding energies of 02j (-4.10kcal/mol) and PJE (-5.07kcal.mol). Six compounds (CID_99615 = -10.24kcal/mol, CID_3981360 = 9.75kcal/mol, CID_9910474 = -9.14kcal/mol, CID_11697907 = -9.10kcal/mol, CID_10503282 = -9.09kcal/mol and CID_620012 = -8.53kcal/mol) with good binding energies further selected and subjected to MD Simulation to determine the stability of the protein-ligand complex. The results of the analysis indicated that all the ligands form stable complexes with the protein, although, CID_9910474 and CID_10503282 had a better stability when compared to other selected phytochemicals (CID_99615, CID_3981360, CID_620012, and CID_11697907).

Download Full-text

In Silico Molecular Docking and Molecular Dynamic Simulation of Potential Inhibitors of 3C-like Main Proteinase (3CLpro) from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Using Selected African Medicinal Plants

10.26434/chemrxiv.12480434 ◽

2020 ◽

Author(s):

Sahar Qazi ◽

Mustafa Alhaji Isa ◽

Adam Mustapha ◽

Khalid Raza ◽

Ibrahim Alkali Allamin ◽

...

Keyword(s):

Molecular Docking ◽

Severe Acute Respiratory Syndrome ◽

In Silico ◽

Md Simulation ◽

Binding Energies ◽

Anacardium Occidentale ◽

Upper Respiratory Tract ◽

Ligand Complex ◽

In Silico Docking ◽

Main Protease

The Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) is an infectious virus that causes mild to severe life-threatening upper respiratory tract infection. The virus emerged in Wuhan, China in 2019, and later spread across the globe. Its genome has been completely sequenced and based on the genomic information, the virus possessed 3C-Like Main Protease (3CLpro), an essential multifunctional enzyme that plays a vital role in the replication and transcription of the virus by cleaving polyprotein at eleven various sites to produce different non-structural proteins. This makes the protein an important target for drug design and discovery. Herein, we analyzed the interaction between the 3CLpro and potential inhibitory compounds identified from the extracts of Zingiber offinale and Anacardium occidentale using in silico docking and Molecular Dynamics (MD) Simulation. The crystal structure of SARS-CoV-2 main protease in complex with 02J (5-Methylisoxazole-3-carboxylic acid) and PEJ (composite ligand) (PDB Code: 6LU7,2.16Å) retrieved from Protein Data Bank (PDB) and subject to structure optimization and energy minimization. A total of twenty-nine compounds were obtained from the extracts of Zingiber offinale and the leaves of Anacardium occidentale. These compounds were screened for physicochemical (Lipinski rule of five, Veber rule, and Egan filter), Pan-Assay Interference Structure (PAINS), and pharmacokinetic properties to determine the Pharmaceutical Active Ingredients (PAIs). Of the 29 compounds, only nineteen (19) possessed drug-likeness properties with efficient oral bioavailability and less toxicity. These compounds subjected to molecular docking analysis to determine their binding energies with the 3CLpro. The result of the analysis indicated that the free binding energies of the compounds ranged between ˗5.08 and -10.24kcal/mol, better than the binding energies of 02j (-4.10kcal/mol) and PJE (-5.07kcal.mol). Six compounds (CID_99615 = -10.24kcal/mol, CID_3981360 = 9.75kcal/mol, CID_9910474 = -9.14kcal/mol, CID_11697907 = -9.10kcal/mol, CID_10503282 = -9.09kcal/mol and CID_620012 = -8.53kcal/mol) with good binding energies further selected and subjected to MD Simulation to determine the stability of the protein-ligand complex. The results of the analysis indicated that all the ligands form stable complexes with the protein, although, CID_9910474 and CID_10503282 had a better stability when compared to other selected phytochemicals (CID_99615, CID_3981360, CID_620012, and CID_11697907).

Download Full-text

The relevance of dietetic approach of Ayurveda from the perspective of COVID-19 pandemic

International Journal of Research in Pharmaceutical Sciences ◽

10.26452/ijrps.v11ispl1.3077 ◽

2020 ◽

Vol 11 (SPL1) ◽

pp. 748-752

Author(s):

Swapnali Khabade ◽

Bharat Rathi ◽

Renu Rathi

Keyword(s):

Severe Acute Respiratory Syndrome ◽

Healthy Person ◽

World Health ◽

Physical And Mental Health ◽

Leading Role ◽

Global Pandemic ◽

The People ◽

The World ◽

Health Organization ◽

The Individual

A novel, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes severe acute respiratory syndrome and spread globally from Wuhan, China. In March 2020 the World Health Organization declared the SARS-Cov-2 virus as a COVID- 19, a global pandemic. This pandemic happened to be followed by some restrictions, and specially lockdown playing the leading role for the people to get disassociated with their personal and social schedules. And now the food is the most necessary thing to take care of. It seems the new challenge for the individual is self-isolation to maintain themselves on the health basis and fight against the pandemic situation by boosting their immunity. Food organised by proper diet may maintain the physical and mental health of the individual. Ayurveda aims to promote and preserve the health, strength and the longevity of the healthy person and to cure the disease by properly channelling with and without Ahara. In Ayurveda, diet (Ahara) is considered as one of the critical pillars of life, and Langhana plays an important role too. This article will review the relevance of dietetic approach described in Ayurveda with and without food (Asthavidhi visheshaytana & Lanhgan) during COVID-19 like a pandemic.

Download Full-text